Efficacy of single-agent chemotherapy with pegylated liposomal doxorubicin or gemcitabine in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma

Br J Dermatol. 2024 Feb 16;190(3):436-438. doi: 10.1093/bjd/ljad311.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Gemcitabine
  • Humans
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Polyethylene Glycols / therapeutic use
  • Skin Neoplasms* / drug therapy

Substances

  • Gemcitabine
  • liposomal doxorubicin
  • Doxorubicin
  • Polyethylene Glycols